Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia
- PMID: 18393909
- DOI: 10.2174/157016108783955301
Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia
Abstract
Chronic volume/pressure overload-induced heart failure augments oxidative stress and activates matrix metalloproteinase which causes endocardial endothelial-myocyte (EM) uncoupling eventually leading to decline in myocardial systolic and diastolic function. The elevated levels of homocysteine (Hcy), hyperhomocysteinemia (HHcy), are associated with decline in cardiac performance. Hcy impairs the EM functions associated with the induction of ventricular hypertrophy leading to cardiac stiffness and diastolic heart failure. Hcy-induced neurological defects are mediated by the NMDA-R (N-methyl-D-aspartate (NMDA) receptor) activation. NMDA-R is expressed in the heart. However, the role of NMDA-R on cardiac function during HHcy is still in its infancy. The blockade of NMDA-R attenuates NMDA-agonist-induced increase in the heart rate. Hcy increases intracellular calcium and activates calpain and calpain-associated mitochondrial (mt) abnormalities have been identified in HHcy. Mitochondrial permeabilization and uncoupling in the pathological setting is fueled by redox stress and calcium mishandling. Recently the role of cyclophilin D, a component of the mitochondrial membrane permeability transition pore, has been identified in cardiac-ischemia. Mechanisms underlying the potentiation between NMDA-R activation and mitochondrial defects leading to cardiac dysfunction during HHcy remain to be elucidated. This review addresses the mitochondrial mechanism by which Hcy contributes to the decline in mechano-electrical function and arrhythmogenesis via agonizing NMDA-R. The putative role of mitochondrial MMP activation, protease stress and mitochondrial permeability transition in cardiac conduction during HHcy is discussed. The review suggests that Hcy increases calcium overload and oxidative stress in the mitochondria and amplifies the activation of mtMMP, causing the opening of mitochondrial permeability transition pore leading to mechano-electrical dysfunction.
Similar articles
-
Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H890-7. doi: 10.1152/ajpheart.00099.2008. Epub 2008 Jun 20. Am J Physiol Heart Circ Physiol. 2008. PMID: 18567713 Free PMC article.
-
Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H887-92. doi: 10.1152/ajpheart.00750.2008. Epub 2009 Jan 30. Am J Physiol Heart Circ Physiol. 2009. PMID: 19181966 Free PMC article.
-
Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.Arch Physiol Biochem. 2006 Oct-Dec;112(4-5):219-27. doi: 10.1080/13813450601093443. Arch Physiol Biochem. 2006. PMID: 17178594 Free PMC article. Review.
-
Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia.J Recept Signal Transduct Res. 2010 Apr;30(2):78-87. doi: 10.3109/10799891003614808. J Recept Signal Transduct Res. 2010. PMID: 20170426 Free PMC article.
-
Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms.Curr Vasc Pharmacol. 2010 Jan;8(1):64-74. doi: 10.2174/157016110790226552. Curr Vasc Pharmacol. 2010. PMID: 19485933 Review.
Cited by
-
Plasma homocysteine levels associated with a corrected QT interval.BMC Cardiovasc Disord. 2017 Jul 11;17(1):182. doi: 10.1186/s12872-017-0617-z. BMC Cardiovasc Disord. 2017. PMID: 28693429 Free PMC article.
-
The role of homocysteine in bone remodeling.Clin Chem Lab Med. 2013 Mar 1;51(3):579-90. doi: 10.1515/cclm-2012-0605. Clin Chem Lab Med. 2013. PMID: 23449525 Free PMC article. Review.
-
Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.Neurochem Int. 2008 Dec;53(6-8):214-9. doi: 10.1016/j.neuint.2008.07.008. Epub 2008 Aug 3. Neurochem Int. 2008. PMID: 18725259 Free PMC article.
-
Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H890-7. doi: 10.1152/ajpheart.00099.2008. Epub 2008 Jun 20. Am J Physiol Heart Circ Physiol. 2008. PMID: 18567713 Free PMC article.
-
Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H887-92. doi: 10.1152/ajpheart.00750.2008. Epub 2009 Jan 30. Am J Physiol Heart Circ Physiol. 2009. PMID: 19181966 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical